gopubmed logo
 
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 02 Oct 2014.

Orosomucoid 1

Orosomucoid, alpha1-acid glycoprotein
This gene encodes a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined; however, it may be involved in aspects of immunosuppression. [provided by RefSeq, Jul 2008] (from NCBI)
Top mentioned proteins: ACID, CD45, Alpha-1, Serum albumin, HAD
Papers using Orosomucoid antibodies
Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms
Supplier
Sang Qing-Xiang Amy et al., In Journal of Cancer, 2005
... Rabbit polyclonal anti-human alpha-1-acid glycoprotein ab440-2 (MW ~50 kDa) was bought from Abcam.
Papers on Orosomucoid
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer.
New
Petros et al., Morgantown, United States. In Cancer Chemother Pharmacol, May 2014
Pharmacogenomics of alpha-1-acid glycoprotein (AAG) were also explored.
ORMDL3 transgenic mice have increased airway remodeling and airway responsiveness characteristic of asthma.
New
Broide et al., San Diego, United States. In J Immunol, May 2014
Orosomucoid-like (ORMDL)3 has been strongly linked with asthma in genetic association studies.
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons.
New
Metspalu et al., Tartu, Estonia. In Plos Med, Feb 2014
Four circulating biomarkers predicted the risk of all-cause mortality among participants from the Estonian Biobank after adjusting for conventional risk factors: alpha-1-acid glycoprotein (hazard ratio [HR] 1.67 per 1-standard deviation increment, 95% CI 1.53-1.82,
Use of biomarkers in the management of children with lupus.
Review
New
Edelbauer et al., Innsbruck, Austria. In Curr Rheumatol Rep, Mar 2013
The most promising biomarkers in juvenile-onset SLE include cell-bound complement activation products, some genomic profiles, and urinary proteins such as neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein-1, and alpha-1-acid glycoprotein.
Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics.
Review
New
Ung et al., Rockville, United States. In Curr Drug Metab, Feb 2013
Alpha-1-acid glycoprotein (AGP, also known as AAG or orosomucoid) is an important plasma protein involved in the binding and transport of many drugs, especially basic compounds.
Relationship between acute phase proteins and serum fatty acid composition in morbidly obese patients.
Trindade et al., Florianópolis, Brazil. In Dis Markers, 2012
OBJECTIVE: To investigate the relationship between acute phase proteins (C-Reactive Protein, Orosomucoid, and Albumin) and serum fatty acids in morbidly obese patients.
The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
Jaisser et al., Paris, France. In Plos One, 2012
Spironolactone blocked the induction by aldosterone of endogenous MR-responsive genes (Sgk-1, PAI-1, Orosomucoid-1, Rgs-2, Serpina-3, Tenascin-X), while torasemide was ineffective.
The urine proteome as a radiation biodosimeter.
Review
Moulder et al., Kansas City, United States. In Adv Exp Med Biol, 2012
Analysis of acute-phase response proteins and markers of acute kidney injury showed increased urinary levels of cystatin superfamily proteins and alpha-1-acid glycoprotein.
Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases.
Hanash et al., Seattle, United States. In Genome Med, 2012
METHODS: Five proteins potentially associated with CHD (beta-2 microglobulin (B2M), alpha-1-acid glycoprotein 1 (ORM1), thrombospondin-1(THBS1), complement factor D pre-protein (CFD), and insulin-like growth factor binding protein 1 (IGFBP1)) and five potentially associated with stroke (B2M, IGFBP2, IGFBP4, IGFBP6, and hemopexin (HPX)) had high discovery phase significance level ranking and an available ELISA assay, and were included in case-control validation studies within the Women's Health Initiative (WHI) hormone therapy trials.
α(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress.
GeneRIF
Maruyama et al., Kumamoto, Japan. In J Biol Chem, 2012
alpha(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress.
Structure-activity relationships for the binding of polymyxins with human α-1-acid glycoprotein.
GeneRIF
Velkov et al., Australia. In Biochem Pharmacol, 2012
The binding properties of the polymyxin class of antibiotics for human alpha-1-acid glycoprotein (AGP) have been characterized.
Association of elevated α₁-acid glycoprotein (AGP) and the prevalence of anemia in Nicaraguan preschool children.
GeneRIF
Halleslevens et al., Atlanta, United States. In Food Nutr Bull, 2012
Analyses of Nicaraguan population surveillance data suggest that preschool children with elevated AGP1 levels have higher prevalence of anemia than children with normal AGP1 levels.
[The investigation of alpha1-antitripsin, orozomukoid and ceruloplasmin in peripheral blood and oral fluid. Paradontitis is one of more risk factors of cardiovascular diseases].
GeneRIF
Zubarev et al., In Patol Fiziol Eksp Ter, 2012
change of the maintenance of three acute phase proteins: ceruloplasmin, alpha1-antitripsin and orosomucoid in an oral fluid and blood plasma at paradontitis and myocardial infarction
Characterization of 6-mercaptopurine binding site on human alpha1-acid glycoprotein (orosomucoid) using molecular docking.
GeneRIF
Pawełczak et al., Sosnowiec, Poland. In Acta Pol Pharm, 2012
Characterization of 6-mercaptopurine binding site on human alpha1-acid glycoprotein (orosomucoid) using molecular docking.
[Psychotropic medication of elderly patients].
Review
Iseki et al., Tokyo, Japan. In Nihon Rinsho, 2012
Drugs medicated for elderly patients show different pharmacokinetics from young patients, because of change in the makeup of bodies, decrease of albumin, increase of alpha-1-acid glycoprotein, hypofunction of metabolism, and excretion by aging.
Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors.
Review
Orfi et al., Budapest, Hungary. In Curr Med Chem, 2008
There are about 380 protein kinase inhibitors in drug development as of today and 15 drugs have been marketed already for the treatment of cancer.
Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies.
Impact
Lee et al., Singapore, Singapore. In J Clin Oncol, 2002
In multiple linear regression analyses, midazolam clearance and performance status were the only significant covariates of docetaxel clearance, and the area under the curve of docetaxel, serum levels of alpha-1-acid glycoprotein, and ALT were significant predictors of nadir neutrophil count.
Correlation between docetaxel clearance and estimated cytochrome P450 activity by urinary metabolite of exogenous cortisol.
Impact
Saijo et al., Tokyo, Japan. In J Clin Oncol, 2000
In multivariate analysis, T6beta-OHF (P <.001), alpha-1-acid glycoprotein (P <.004), AST (P =.007), and age (P =. 022) significantly correlated with docetaxel CL.
Plasma free amino acid profiles and nutrition proteins in chronic renal failure; effect of dialysis treatment.
Jacobs et al., Paris, France. In Amino Acids, 1992
Non inflammatory reaction was evaluated by determination of alpha-1-acid glycoprotein, and C reactive protein.
Evaluation of three biochemical markers for serially monitoring the therapy of small-cell lung cancer.
Impact
Elashoff et al., In J Clin Oncol, 1987
This report reviews the experience at a single institution using three biochemical markers, alpha-1-acid glycoprotein (AGP), carcinoembryonic antigen (CEA), and lactate dehydrogenase (LDH), for serially monitoring the therapy of patients with SCLC.
share on facebooktweetadd +1mail to friends